Rapid Infection Diagnostics Inc. (RID) was founded with the mission of reducing death and disability from infectious diseases via state-of-the-art diagnostic technology. RID leverages advanced mass spectrometry to enable a suite rapid diagnostic tests that reduce microbiology testing times from days to hours.